Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1994 Aug 1;301(Pt 3):911–916. doi: 10.1042/bj3010911

Agonist-induced down-regulation of platelet-activating factor receptor gene expression in U937 cells.

L Y Chau 1, K Peck 1, H H Yen 1, J Y Wang 1
PMCID: PMC1137072  PMID: 7519853

Abstract

Prolonged exposure (8-24 h) of human promonocytic U937 cells to 100 nM 1-O-hexadecyl-2-N-methylcarbamyl-sn-glycero-3-phosphocholine (carbarmyl-PAF), a non-metabolizable analogue of platelet-activating factor (PAF), reduced the numbers of PAF receptors by 50-75%, as determined by the radioligand-binding assay. To clarify whether the down-regulation of receptor numbers is due to decreased expression level of the PAF-receptor gene, the effect of carbamyl-PAF on the steady-state level of PAF-receptor mRNA was examined by a highly sensitive reverse-transcriptase PCR method. A 50% decline in the level of PAF-receptor mRNA was observed in U937 cells pretreated with 100 nM carbamyl-PAF for 24 h. The effect of carbamyl-PAF was dose-dependent, with an EC50 value around 10 nM. PAF-receptor antagonist, SRI-63675, was able to attenuate the effect of carbamyl-PAF. Furthermore lysoPAF, at 1 uM, was unable to induce a significant decrease in PAF-receptor mRNA after incubation for 24 h, indicating that the effect of carbamyl-PAF was specific. The half-life of the PAF-receptor mRNA measured in the presence of actinomycin D was unaffected by carbamyl-PAF treatment. In contrast, nuclear run-off experiments demonstrated that the transcription rate of the PAF-receptor gene in carbamyl-PAF-treated cells was about 65% of that in control cells. These results suggest that the PAF receptor in U937 cells is subject to down-regulation by agonist, at least partly, at the transcriptional level.

Full text

PDF
911

Images in this article

913Figure 1
on p.913
915Figure 4
on p.915
915Figure 5
on p.915

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balsinde J., Mollinedo F. Platelet-activating factor synergizes with phorbol myristate acetate in activating phospholipase D in the human promonocytic cell line U937. Evidence for different mechanisms of activation. J Biol Chem. 1991 Oct 5;266(28):18726–18730. [PubMed] [Google Scholar]
  2. Barzaghi G., Sarau H. M., Mong S. Platelet-activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture. J Pharmacol Exp Ther. 1989 Feb;248(2):559–566. [PubMed] [Google Scholar]
  3. Benovic J. L., Bouvier M., Caron M. G., Lefkowitz R. J. Regulation of adenylyl cyclase-coupled beta-adrenergic receptors. Annu Rev Cell Biol. 1988;4:405–428. doi: 10.1146/annurev.cb.04.110188.002201. [DOI] [PubMed] [Google Scholar]
  4. Berridge M. J. Inositol trisphosphate and diacylglycerol: two interacting second messengers. Annu Rev Biochem. 1987;56:159–193. doi: 10.1146/annurev.bi.56.070187.001111. [DOI] [PubMed] [Google Scholar]
  5. Bouvier M., Hausdorff W. P., De Blasi A., O'Dowd B. F., Kobilka B. K., Caron M. G., Lefkowitz R. J. Removal of phosphorylation sites from the beta 2-adrenergic receptor delays onset of agonist-promoted desensitization. Nature. 1988 May 26;333(6171):370–373. doi: 10.1038/333370a0. [DOI] [PubMed] [Google Scholar]
  6. Braquet P., Touqui L., Shen T. Y., Vargaftig B. B. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987 Jun;39(2):97–145. [PubMed] [Google Scholar]
  7. Chau L. Y., Hu C. Y., Chang W. T., Hsu Y. S. Possible existence of two subsets of platelet-activating factor receptor to mediate polyphosphoinositide breakdown and calcium influx in neuroblastoma x glioma hybrid NG 108-15 cells. J Neurochem. 1992 Sep;59(3):1090–1098. doi: 10.1111/j.1471-4159.1992.tb08351.x. [DOI] [PubMed] [Google Scholar]
  8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  9. Dohlman H. G., Thorner J., Caron M. G., Lefkowitz R. J. Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem. 1991;60:653–688. doi: 10.1146/annurev.bi.60.070191.003253. [DOI] [PubMed] [Google Scholar]
  10. Espinoza-Delgado I., Longo D. L., Gusella G. L., Varesio L. Regulation of IL-2 receptor subunit genes in human monocytes. Differential effects of IL-2 and IFN-gamma. J Immunol. 1992 Nov 1;149(9):2961–2968. [PubMed] [Google Scholar]
  11. Galper J. B., Dziekan L. C., O'Hara D. S., Smith T. W. The biphasic response of muscarinic cholinergic receptors in cultured heart cells to agonists. Effects on receptor number and affinity in intact cells and homogenates. J Biol Chem. 1982 Sep 10;257(17):10344–10356. [PubMed] [Google Scholar]
  12. Galper J. B., Smith T. W. Agonist and guanine nucleotide modulation of muscarinic cholinergic receptors in cultured heart cells. J Biol Chem. 1980 Oct 25;255(20):9571–9579. [PubMed] [Google Scholar]
  13. Glazer A. N., Peck K., Mathies R. A. A stable double-stranded DNA-ethidium homodimer complex: application to picogram fluorescence detection of DNA in agarose gels. Proc Natl Acad Sci U S A. 1990 May;87(10):3851–3855. doi: 10.1073/pnas.87.10.3851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Grandison L. Platelet activating factor induces inositol phosphate accumulation in cultures of rat and bovine anterior pituitary cells. Endocrinology. 1990 Oct;127(4):1786–1791. doi: 10.1210/endo-127-4-1786. [DOI] [PubMed] [Google Scholar]
  15. Habecker B. A., Nathanson N. M. Regulation of muscarinic acetylcholine receptor mRNA expression by activation of homologous and heterologous receptors. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5035–5038. doi: 10.1073/pnas.89.11.5035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Habecker B. A., Wang H., Nathanson N. M. Multiple second-messenger pathways mediate agonist regulation of muscarinic receptor mRNA expression. Biochemistry. 1993 May 18;32(19):4986–4990. doi: 10.1021/bi00070a003. [DOI] [PubMed] [Google Scholar]
  17. Hadcock J. R., Malbon C. C. Down-regulation of beta-adrenergic receptors: agonist-induced reduction in receptor mRNA levels. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5021–5025. doi: 10.1073/pnas.85.14.5021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hadcock J. R., Wang H. Y., Malbon C. C. Agonist-induced destabilization of beta-adrenergic receptor mRNA. Attenuation of glucocorticoid-induced up-regulation of beta-adrenergic receptors. J Biol Chem. 1989 Nov 25;264(33):19928–19933. [PubMed] [Google Scholar]
  19. Hanahan D. J. Platelet activating factor: a biologically active phosphoglyceride. Annu Rev Biochem. 1986;55:483–509. doi: 10.1146/annurev.bi.55.070186.002411. [DOI] [PubMed] [Google Scholar]
  20. Handley D. A., Van Valen R. G., Winslow C. M., Tomesch J. C., Saunders R. N. In vitro and in vivo pharmacological profiles of the PAF receptor antagonist SRI 63-675. Thromb Haemost. 1987 Apr 7;57(2):187–190. [PubMed] [Google Scholar]
  21. Homma H., Hanahan D. J. Attenuation of platelet activating factor (PAF)-induced stimulation of rabbit platelet GTPase by phorbol ester, dibutyryl cAMP, and desensitization: concomitant effects on PAF receptor binding characteristics. Arch Biochem Biophys. 1988 Apr;262(1):32–39. doi: 10.1016/0003-9861(88)90165-8. [DOI] [PubMed] [Google Scholar]
  22. Honda Z., Nakamura M., Miki I., Minami M., Watanabe T., Seyama Y., Okado H., Toh H., Ito K., Miyamoto T. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature. 1991 Jan 24;349(6307):342–346. doi: 10.1038/349342a0. [DOI] [PubMed] [Google Scholar]
  23. Klein W. L., Nathanson N., Nirenberg M. Muscarinic acetylcholine receptor regulation by accelerated rate of receptor loss. Biochem Biophys Res Commun. 1979 Sep 27;90(2):506–512. doi: 10.1016/0006-291x(79)91264-6. [DOI] [PubMed] [Google Scholar]
  24. Kunz D., Gerard N. P., Gerard C. The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog. J Biol Chem. 1992 May 5;267(13):9101–9106. [PubMed] [Google Scholar]
  25. Lee H. K., Xia X., Choi Y. S. IL-4 blocks the up-regulation of IL-2 receptors induced by IL-2 in normal human B cells. J Immunol. 1990 May 1;144(9):3431–3436. [PubMed] [Google Scholar]
  26. Lohse M. J., Benovic J. L., Caron M. G., Lefkowitz R. J. Multiple pathways of rapid beta 2-adrenergic receptor desensitization. Delineation with specific inhibitors. J Biol Chem. 1990 Feb 25;265(6):3202–3211. [PubMed] [Google Scholar]
  27. Longone P., Mocchetti I., Riva M. A., Wojcik W. J. Characterization of a decrease in muscarinic m2 mRNA in cerebellar granule cells by carbachol. J Pharmacol Exp Ther. 1993 Apr;265(1):441–446. [PubMed] [Google Scholar]
  28. Moolenaar W. H., Kruijer W., Tilly B. C., Verlaan I., Bierman A. J., de Laat S. W. Growth factor-like action of phosphatidic acid. Nature. 1986 Sep 11;323(6084):171–173. doi: 10.1038/323171a0. [DOI] [PubMed] [Google Scholar]
  29. Morrison W. J., Shukla S. D. Desensitization of receptor-coupled activation of phosphoinositide-specific phospholipase C in platelets: evidence for distinct mechanisms for platelet-activating factor and thrombin. Mol Pharmacol. 1988 Jan;33(1):58–63. [PubMed] [Google Scholar]
  30. Nakamura M., Honda Z., Izumi T., Sakanaka C., Mutoh H., Minami M., Bito H., Seyama Y., Matsumoto T., Noma M. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem. 1991 Oct 25;266(30):20400–20405. [PubMed] [Google Scholar]
  31. O'Flaherty J. T., Redman J. F., Jr, Schmitt J. D., Ellis J. M., Surles J. R., Marx M. H., Piantadosi C., Wykle R. L. 1-O-alkyl-2-N-methylcarbamyl-glycerophosphocholine: a biologically potent, non-metabolizable analog of platelet-activating factor. Biochem Biophys Res Commun. 1987 Aug 31;147(1):18–24. doi: 10.1016/s0006-291x(87)80081-5. [DOI] [PubMed] [Google Scholar]
  32. Ong R. C., Yoo T. J., Chiang T. M. Activation mechanisms of platelet-activating factor in U937 cells: possible involvement of protein kinase C. Cell Immunol. 1991 Oct 15;137(2):283–291. doi: 10.1016/0008-8749(91)90079-q. [DOI] [PubMed] [Google Scholar]
  33. Renz H., Domenico J., Gelfand E. W. IL-4-dependent up-regulation of IL-4 receptor expression in murine T and B cells. J Immunol. 1991 May 1;146(9):3049–3055. [PubMed] [Google Scholar]
  34. Rye H. S., Quesada M. A., Peck K., Mathies R. A., Glazer A. N. High-sensitivity two-color detection of double-stranded DNA with a confocal fluorescence gel scanner using ethidium homodimer and thiazole orange. Nucleic Acids Res. 1991 Jan 25;19(2):327–333. doi: 10.1093/nar/19.2.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Schwertschlag U. S., Whorton A. R. Platelet-activating factor-induced homologous and heterologous desensitization in cultured vascular smooth muscle cells. J Biol Chem. 1988 Sep 25;263(27):13791–13796. [PubMed] [Google Scholar]
  36. Shimizu T., Honda Z., Nakamura M., Bito H., Izumi T. Platelet-activating factor receptor and signal transduction. Biochem Pharmacol. 1992 Sep 25;44(6):1001–1008. doi: 10.1016/0006-2952(92)90360-u. [DOI] [PubMed] [Google Scholar]
  37. Shukla S. D. Platelet-activating factor receptor and signal transduction mechanisms. FASEB J. 1992 Mar;6(6):2296–2301. doi: 10.1096/fasebj.6.6.1312046. [DOI] [PubMed] [Google Scholar]
  38. Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol. 1990 Nov;259(5 Pt 1):C697–C708. doi: 10.1152/ajpcell.1990.259.5.C697. [DOI] [PubMed] [Google Scholar]
  39. Steel M. C., Buckley N. J. Differential regulation of muscarinic receptor mRNA levels in neuroblastoma cells by chronic agonist exposure: a comparative polymerase chain reaction study. Mol Pharmacol. 1993 May;43(5):694–701. [PubMed] [Google Scholar]
  40. Tessner T. G., O'Flaherty J. T., Wykle R. L. Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites. J Biol Chem. 1989 Mar 25;264(9):4794–4799. [PubMed] [Google Scholar]
  41. Thivierge M., Alami N., Müller E., de Brum-Fernandes A. J., Rola-Pleszczynski M. Transcriptional modulation of platelet-activating factor receptor gene expression by cyclic AMP. J Biol Chem. 1993 Aug 15;268(23):17457–17462. [PubMed] [Google Scholar]
  42. Venable M. E., Zimmerman G. A., McIntyre T. M., Prescott S. M. Platelet-activating factor: a phospholipid autacoid with diverse actions. J Lipid Res. 1993 May;34(5):691–702. [PubMed] [Google Scholar]
  43. Ye R. D., Prossnitz E. R., Zou A. H., Cochrane C. G. Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochem Biophys Res Commun. 1991 Oct 15;180(1):105–111. doi: 10.1016/s0006-291x(05)81261-6. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES